Tu Xu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tu Xu

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Blood|October 12, 2017

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myelomaShaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II StudyAndrew H Wei, Stephen A Strickland, Jing-Zhou Hou, et al.

Science Translational Medicine|June 15, 2018

Statins enhance efficacy of venetoclax in blood cancersJ Scott Lee, Andrew Roberts, Dennis Juarez, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Blood|October 12, 2017

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myelomaShaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II StudyAndrew H Wei, Stephen A Strickland, Jing-Zhou Hou, et al.

Science Translational Medicine|June 15, 2018

Statins enhance efficacy of venetoclax in blood cancersJ Scott Lee, Andrew Roberts, Dennis Juarez, et al.

Pageof 3